Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Saltagen Ventures Limited, founded in 2017, is headquartered in Hong Kong. The firm focuses on early-stage investments in biotechnology startups that demonstrate the potential to scale across North America and Asia. Saltagen Ventures aims to support startups in growing their businesses globally by leveraging strong local partnerships and maintaining a presence in both Canada and China.
Since its inception, Saltagen Ventures has built a diverse portfolio of 22 companies, emphasizing biotechnology and healthcare innovation. The firm has established itself as a key player in the early-stage investment landscape, particularly in sectors such as precision medicine and agricultural innovation. Saltagen Ventures has a commitment to follow-on investments, ensuring that successful portfolio companies receive the necessary capital to continue their growth.
Saltagen Ventures specializes in early-stage investments, particularly within the biotechnology sector. Their investment focus encompasses precision medicine, the fourth agricultural revolution, and nanotechnology. The firm typically invests in companies at the seed, Series A, and Series B stages, reserving capital for follow-on investments in successful ventures.
Geographically, Saltagen Ventures targets opportunities in North America and Asia, leveraging its presence in Canada and China to identify promising startups. The firm seeks to partner with founders who demonstrate a strong vision and the capability to scale their businesses globally. Saltagen Ventures emphasizes the importance of local partnerships and market understanding in its investment strategy.
Saltagen Ventures has a notable portfolio of 22 companies, showcasing its commitment to biotechnology and healthcare innovation. Key portfolio companies include:
This diverse portfolio reflects Saltagen Ventures' commitment to supporting innovative companies that are positioned to thrive in the biotechnology sector.
Joseph Fung - Managing Partner & Responsible Officer. Joseph has extensive experience in venture capital and has led numerous successful investments in the biotechnology sector.
Alan Chen - Investment Team. Alan brings a strong background in finance and investment analysis, focusing on identifying promising biotech startups.
Emmanuel Hui - Investment Team. Emmanuel has expertise in operational support and strategic guidance for portfolio companies.
Jason Chiu - Investment Team. Jason specializes in market analysis and has a keen eye for emerging trends in biotechnology.
Simon Lai - Investment Team. Simon has a background in healthcare innovation and works closely with portfolio companies to enhance their growth strategies.
Yina Chan - Investment Team. Yina focuses on deal sourcing and relationship management within the biotechnology ecosystem.
Henry Lau - Investment Team. Henry has experience in financial modeling and investment strategy, contributing to the firm's analytical capabilities.
Jimmy Lai - Investment Team. Jimmy specializes in technology assessment and due diligence for potential investments.
Elsa Lee - Investment Team. Elsa has a strong background in biotech research and development, providing valuable insights to portfolio companies.
Frances Law - Investment Team. Frances focuses on operational efficiency and scaling strategies for startups.
To pitch Saltagen Ventures, founders should email their pitch deck to info@saltagen.com. The deck should include an overview of the business model, market opportunity, competitive landscape, and team background. Founders are encouraged to provide detailed information about their technology and growth strategy.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, but cold emails are also accepted.
Since its founding in 2017, Saltagen Ventures has actively engaged with the biotechnology ecosystem, building a diverse portfolio of innovative companies. Recent updates highlight their commitment to supporting startups that can thrive in both North American and Asian markets.
Notable portfolio companies such as Phase Scientific and Hylid Diagnostics have made significant strides in their respective fields, showcasing the effectiveness of Saltagen Ventures' investment strategy. The firm continues to seek new opportunities in the biotechnology sector, emphasizing its focus on early-stage investments.
What are Saltagen Ventures' investment criteria?
Saltagen Ventures focuses on early-stage investments in biotechnology startups, particularly those involved in precision medicine, agricultural innovation, and nanotechnology. They typically invest from seed to Series B stages and prioritize companies with strong growth potential in North America and Asia.
How can I apply or pitch to Saltagen Ventures?
Founders can reach out to Saltagen Ventures via email at info@saltagen.com. It is advisable to provide a detailed pitch deck that outlines the business model, market opportunity, and team background.
What makes Saltagen Ventures different from other investors?
Saltagen Ventures distinguishes itself through its strong local partnerships in both Canada and China, enabling startups to scale their operations effectively across North America and Asia. Their focus on biotechnology and commitment to follow-on investments further enhance their value proposition.
What is the geographic scope of Saltagen Ventures?
The firm primarily invests in North America and Asia, leveraging its presence in these regions to identify and support promising biotechnology startups.
What is the typical check size for investments?
While specific check sizes are not disclosed, Saltagen Ventures typically invests in early-stage rounds, which can range from seed funding to Series B investments, allowing for flexibility based on the startup's needs.
What kind of post-investment involvement does Saltagen Ventures have?
Saltagen Ventures emphasizes follow-on investments for successful portfolio companies, indicating a commitment to supporting their growth beyond the initial funding round. They also leverage their network to provide operational support and strategic guidance.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.